nVerses Capital’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
GA
nVerses Capital's TMCI Position: Q3 2026 in Review
nVerses Capital sold out of Treace Medical Concepts (TMCI) in Q3 2026, closing a stake of 10,696 shares — an estimated $42.6K sold.
nVerses Capital first reported a position in TMCI in Q2 2026 and held it in 1 quarter. The position peaked at $42.6K in Q2 2026. 116 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.
- nVerses Capital reported no remaining Treace Medical Concepts position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 10,696 Treace Medical Concepts shares in Q3 2026, an estimated $42.6K.
- nVerses Capital first reported a position in Treace Medical Concepts in Q2 2026 and held it in 1 quarter.
- nVerses Capital's Treace Medical Concepts position peaked at $42.6K in Q2 2026.
- 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.